Anti-Integrin alpha V beta 6 Antibody, clone EM05201, ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone EM05201 ZooMAb is a rabbit recombinant monoclonal antibody that specifically detects integrin alpha V beta 6.
• Immunogen: Recombinant transmembrane-truncated (DTM) extracellular domains of human integrins avb3, avb5, avb6, and avb8.Recombinant fragments corresponding to amino acids 31-987 of integrin alphaV and 24-706 of integrin beta6.
• Application: Anti-Integrin alpha V beta 6, clone EM05201 ZooMAb , Cat. No. ZRB1104, is a recombinant Rabbit monoclonal antibody that specifically targets Integrin alphaV beta6 and has been tested for use in Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
• Target description: Integrin alphaV beta6 (UniProt: P08648/P18564) is encoded by ITGA5/ITGB6 genes (Gene ID: 3678/3694) in human. Integrins are heterodimeric integral membrane proteins that control cell attachment. Fourteen different alpha chains are reported to associate with 8 beta chains to form 24 receptors. Integrins are differentially glycosylated, spliced, and activated in response to their cellular and extracellular environments. They function in cell surface adhesion and signaling. Integrin alphaV beta6 are single-pass type I heterodimeric membrane proteins that serve as a receptor for fibronectin and cytotactin. It is detected only in epithelial cell lines. It is not expressed in healthy adult epithelia but is shown to be upregulated during wound healing and in cancer. It recognizes the sequence RGD in its ligands. Internalization of integrin alphaV beta6 via clathrin-mediated endocytosis is reported to promote carcinoma cell invasion. Integrin alphaV beta6 is shown to mediate RGD-dependent release of TGF-beta-1 from regulatory latency-associated peptide (LAP) and plays a role in the activation of TGF-beta-1. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Weinacker, A., et al (1994). J. Biol. Chem. 269(9); 6940-6948; Goodman, SL., et al. (2012). Biol Open. 15;1(4):329-40).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose. Normal appearance is a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 300 μg/mL after reconstitution at 25 μL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.